Acadian Asset Management’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
6CM
KGAMU
WPM
RC
QOP
Acadian Asset Management's CDLX Position: Q2 2026 in Review
Acadian Asset Management sold out of Cardlytics (CDLX) in Q2 2026, closing a stake of 3,253 shares — an estimated $34K sold.
Acadian Asset Management first reported a position in CDLX in Q2 2019 and held it in 11 quarters. The position peaked at $3.55M in Q3 2023. 42 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.
- Acadian Asset Management reported no remaining Cardlytics position as of Q2 2026 after selling out during the quarter.
- Acadian Asset Management sold 3,253 Cardlytics shares in Q2 2026, an estimated $34K.
- Acadian Asset Management first reported a position in Cardlytics in Q2 2019 and held it in 11 quarters.
- Acadian Asset Management's Cardlytics position peaked at $3.55M in Q3 2023.
- 42 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.
Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.